Heguan Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Heguan Fu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Cong Han
Department of Neurosurgery Chinese PLA General Hospital Beijing China
2 shared publications - Lian Duan
Chinese PLA General Hospital
2 shared publications Bin Li
Department of Neurosurgery, First Medical Center of Chinese PLA General Hospital, Beijing, China (B.L., H.F., H.D.Z., L.D., C.H.).
1 shared publicationCheng Chen
Medical School of Chinese PLA, Beijing, China
1 shared publication- Gan Gao
Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China
1 shared publication HouDi Zhang
Department of Neurosurgery, First Medical Center of Chinese PLA General Hospital, Beijing, China (B.L., H.F., H.D.Z., L.D., C.H.).
1 shared publication
Latest Publications
- 13 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (7)
Natural Course and Clinical Outcomes of Patients With Hemorrhagic Moyamoya Disease
- 13 October 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (7)
Natural Course and Clinical Outcomes of Patients With Hemorrhagic Moyamoya Disease
- 1 December 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (12) , 3352-3360
Optimizing Surgical Timing to Reduce Stroke Risk in Pediatric Moyamoya Disease
BACKGROUND: Identifying the optimal surgical timing is critical for reducing stroke risk in pediatric patients with moyamoya disease, but evidence to guide clinical decision-making remains limited. This study aimed to determine the optimal surgical timing based on different symptom onset patterns. METHODS: We retrospectively reviewed pediatric patients with moyamoya disease who underwent revascularization surgery at a single center in China between July 2007 and July 2018. Patients were categorized by symptom onset pattern: infarction-onset, transient ischemic attack (TIA)-onset, or nonischemic. The TIA-onset group was further subdivided into high-risk and low-risk subgroups. Data on preoperative/perioperative stroke events and diagnosis-to-operation intervals were collected. Receiver operating characteristic curves and multivariate analyses were used to identify surgical timing thresholds. Stroke incidences were compared across groups stratified by surgical interval. RESULTS: A total of 736 patients (mean age 7.2±3.9 years; 50.7% male) were included. The incidence density of preoperative cerebral infarction was 11.83 per 1000 person-months, while that of cerebral hemorrhage was 1.21 per 1000 person-months. For patients with infarction-onset and high-risk TIA-onset patterns, a surgical waiting time exceeding 2.5 months (area under the curve, 0.722; specificity, 0.561; sensitivity, 0.882; P P =0.006), respectively, was associated with a significantly increased risk of preoperative cerebral infarction. In nonischemic patients, a prolonged surgical waiting time exceeding 5 years (area under the curve, 0.761; specificity, 0.856; sensitivity, 0.571; P <0.05) was associated with a significantly increased risk of cerebral hemorrhage. For patients with initial symptoms of infarction or high-risk TIA, earlier surgery did not increase the incidence of perioperative stroke events. CONCLUSIONS: For children with moyamoya disease, surgical intervention was beneficial within 2.5 months for patients with infarction-onset, 6.5 months for patients with high-risk TIA onset, and 5 years for nonischemic patients in reducing stroke risk.
- 1 December 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (12) , 3352-3360
Optimizing Surgical Timing to Reduce Stroke Risk in Pediatric Moyamoya Disease
BACKGROUND: Identifying the optimal surgical timing is critical for reducing stroke risk in pediatric patients with moyamoya disease, but evidence to guide clinical decision-making remains limited. This study aimed to determine the optimal surgical timing based on different symptom onset patterns. METHODS: We retrospectively reviewed pediatric patients with moyamoya disease who underwent revascularization surgery at a single center in China between July 2007 and July 2018. Patients were categorized by symptom onset pattern: infarction-onset, transient ischemic attack (TIA)-onset, or nonischemic. The TIA-onset group was further subdivided into high-risk and low-risk subgroups. Data on preoperative/perioperative stroke events and diagnosis-to-operation intervals were collected. Receiver operating characteristic curves and multivariate analyses were used to identify surgical timing thresholds. Stroke incidences were compared across groups stratified by surgical interval. RESULTS: A total of 736 patients (mean age 7.2±3.9 years; 50.7% male) were included. The incidence density of preoperative cerebral infarction was 11.83 per 1000 person-months, while that of cerebral hemorrhage was 1.21 per 1000 person-months. For patients with infarction-onset and high-risk TIA-onset patterns, a surgical waiting time exceeding 2.5 months (area under the curve, 0.722; specificity, 0.561; sensitivity, 0.882; P P =0.006), respectively, was associated with a significantly increased risk of preoperative cerebral infarction. In nonischemic patients, a prolonged surgical waiting time exceeding 5 years (area under the curve, 0.761; specificity, 0.856; sensitivity, 0.571; P <0.05) was associated with a significantly increased risk of cerebral hemorrhage. For patients with initial symptoms of infarction or high-risk TIA, earlier surgery did not increase the incidence of perioperative stroke events. CONCLUSIONS: For children with moyamoya disease, surgical intervention was beneficial within 2.5 months for patients with infarction-onset, 6.5 months for patients with high-risk TIA onset, and 5 years for nonischemic patients in reducing stroke risk.